Truist Financial Forecasts Strong Price Appreciation for Astrana Health (NASDAQ:ASTH) Stock

Astrana Health (NASDAQ:ASTH) had its price objective lifted by Truist Financial from $38.00 to $47.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 19.61% from the stock’s previous close.

Several other research firms have also weighed in on ASTH. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. BTIG Research increased their price target on shares of Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research note on Friday, May 8th. TD Cowen increased their price target on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Needham & Company LLC increased their price target on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $43.14.

Astrana Health Stock Down 1.2%

Astrana Health stock traded down $0.47 during trading hours on Thursday, hitting $39.30. The company had a trading volume of 41,316 shares, compared to its average volume of 517,443. The firm has a market capitalization of $2.19 billion, a P/E ratio of 64.19 and a beta of 0.98. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.40. The firm’s fifty day moving average is $28.75 and its 200-day moving average is $25.84. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $39.93.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.45. The firm had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company’s revenue for the quarter was up 55.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.42 EPS. On average, research analysts forecast that Astrana Health will post 1.25 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently added to or reduced their stakes in the company. Signaturefd LLC lifted its holdings in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio bought a new position in Astrana Health during the 4th quarter valued at about $40,000. Covestor Ltd lifted its holdings in Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after purchasing an additional 2,192 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.